NuVasive (NUVA) Tops Q4 EPS by 4c, Offers FY16 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts NUVA Hot Sheet
Join SI Premium – FREE
NuVasive (NASDAQ: NUVA) reported Q4 EPS of $0.35, $0.04 better than the analyst estimate of $0.31. Revenue for the quarter came in at $215.3 million versus the consensus estimate of $215.27 million.
GUIDANCE:
NuVasive sees FY2016 EPS of $1.48, versus the consensus of $1.49. NuVasive sees FY2016 revenue of $923 million, versus the consensus of $881.10 million.
For earnings history and earnings-related data on NuVasive (NUVA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ultragenyx Pharma (RARE) Misses Q3 EPS by 6c; Offers Guidance
- Ovintiv Inc. (OVV) Tops Q3 EPS by 3c
- Limbach Holdings (LMB) Tops Q3 EPS by 16c, Beats on Revenue; Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
